• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The use of FEIBA (factor eight inhibitor bypassing activity) in cataract extraction in hemophilia A patient with inhibitor.

作者信息

Tourbaf K D, Dunlap B E, Ambrus J L, Rodman D J, Atwal A J

出版信息

J Med. 1982;13(5-6):399-410.

PMID:6820380
Abstract

A 34-year-old patient, with severe factor VIII deficiency (anti-hemophilic factor deficiency) and inhibitor against factor VIII, underwent a phacoemulsification with posterior capsulatomy and thermal iridectomy under general anesthesia. FEIBA (Factor Eight Inhibitor Bypassing Activity) was used to achieve hemostasis. The surgical procedure was successful and no complication was ensued. A brief management of hemophilia A patient requiring surgery is discussed.

摘要

相似文献

1
The use of FEIBA (factor eight inhibitor bypassing activity) in cataract extraction in hemophilia A patient with inhibitor.
J Med. 1982;13(5-6):399-410.
2
Disseminated intravascular coagulation after infusion of FEIBA (factor VIII inhibitor bypassing activity) in a patient with acquired haemophilia.
Thromb Haemost. 1982 Dec 27;48(3):339-40.
3
[Clinical effects of FEIBA on hemophilia patients with inhibitors to factor VIII or IX].[活化凝血酶原复合物(FEIBA)对伴有Ⅷ或Ⅸ因子抑制物的血友病患者的临床疗效]
Nihon Ketsueki Gakkai Zasshi. 1982 Sep;45(5):987-92.
4
The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.凝血因子VIII和IX抑制物的诊断与管理:英国血友病中心医生组织指南
Br J Haematol. 2006 Jun;133(6):591-605. doi: 10.1111/j.1365-2141.2006.06087.x.
5
[The problem of factor VIII inhibitors in patients with congenital coagulopathies].
Z Gesamte Inn Med. 1983 Jan 15;38(2):47-50.
6
Laboratory evidence of DIC under FEIBA treatment of a hemophilic patient with intracranial bleeding and high titre factor VIII inhibitor.
Thromb Res. 1981;22(1-2):177-84. doi: 10.1016/0049-3848(81)90319-4.
7
Effects of low-dose 'factor VIII inhibitor bypassing activity (FEIBA)' in resistant haemophilia.
Acta Haematol. 1980;64(1):12-7. doi: 10.1159/000207204.
8
[A case of sigmoid cancer who acquired factor V inhibitor producibility and treated with factor VIII inhibitor bypassing activity preparation FEIBA--with bibliographic review (author's transl)].
Rinsho Ketsueki. 1980 Nov;21(11):1664-73.
9
[Therapy of immuninhibitor hemophilia A with FEIBA plasma fraction].
Orv Hetil. 1980 Dec 21;121(51):3131-5.
10
[Inhibitor hemophilia in oral surgery].
Zahn Mund Kieferheilkd Zentralbl. 1984;72(8):824-8.